Xing L - Search Results

1

Attenuated Joint Tissue Damage Associated With Improved Synovial Lymphatic Function Following Treatment With Bortezomib in a Mouse Model of Experimental Posttraumatic Osteoarthritis.

Wang W, Lin X, Xu H, Sun W, Bouta EM, Zuscik MJ, Chen D, Schwarz EM, Xing L. Wang W, et al. Among authors: xing l. Arthritis Rheumatol. 2019 Feb;71(2):244-257. doi: 10.1002/art.40696. Epub 2019 Jan 5. Arthritis Rheumatol. 2019. PMID: 30144298 Free PMC article.

2

Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis.

Zhang X, Morham SG, Langenbach R, Young DA, Xing L, Boyce BF, Puzas EJ, Rosier RN, O'Keefe RJ, Schwarz EM. Zhang X, et al. Among authors: xing l. J Bone Miner Res. 2001 Apr;16(4):660-70. doi: 10.1359/jbmr.2001.16.4.660. J Bone Miner Res. 2001. PMID: 11315993 Free article.

3

In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis.

Childs LM, Paschalis EP, Xing L, Dougall WC, Anderson D, Boskey AL, Puzas JE, Rosier RN, O'Keefe RJ, Boyce BF, Schwarz EM. Childs LM, et al. Among authors: xing l. J Bone Miner Res. 2002 Feb;17(2):192-9. doi: 10.1359/jbmr.2002.17.2.192. J Bone Miner Res. 2002. PMID: 11811549 Free article.

4

Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice.

Li P, Schwarz EM, O'Keefe RJ, Ma L, Looney RJ, Ritchlin CT, Boyce BF, Xing L. Li P, et al. Among authors: xing l. Arthritis Rheum. 2004 Jan;50(1):265-76. doi: 10.1002/art.11419. Arthritis Rheum. 2004. PMID: 14730625 Free article.

5

RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.

Li P, Schwarz EM, O'Keefe RJ, Ma L, Boyce BF, Xing L. Li P, et al. Among authors: xing l. J Bone Miner Res. 2004 Feb;19(2):207-13. doi: 10.1359/JBMR.0301233. J Bone Miner Res. 2004. PMID: 14969390 Free article.

6

Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.

Zhang Q, Badell IR, Schwarz EM, Boulukos KE, Yao Z, Boyce BF, Xing L. Zhang Q, et al. Among authors: xing l. Arthritis Rheum. 2005 Sep;52(9):2708-18. doi: 10.1002/art.21236. Arthritis Rheum. 2005. PMID: 16142752 Free article.

7

TNF-alpha and pathologic bone resorption.

Boyce BF, Li P, Yao Z, Zhang Q, Badell IR, Schwarz EM, O'Keefe RJ, Xing L. Boyce BF, et al. Among authors: xing l. Keio J Med. 2005 Sep;54(3):127-31. doi: 10.2302/kjm.54.127. Keio J Med. 2005. PMID: 16237274 Free article. Review.

8

Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation.

Shen R, Chen M, Wang YJ, Kaneki H, Xing L, O'keefe RJ, Chen D. Shen R, et al. Among authors: xing l. J Biol Chem. 2006 Feb 10;281(6):3569-76. doi: 10.1074/jbc.M506761200. Epub 2005 Nov 18. J Biol Chem. 2006. PMID: 16299379 Free PMC article.

9

Osteoclast precursors, RANKL/RANK, and immunology.

Xing L, Schwarz EM, Boyce BF. Xing L, et al. Immunol Rev. 2005 Dec;208:19-29. doi: 10.1111/j.0105-2896.2005.00336.x. Immunol Rev. 2005. PMID: 16313338 Review.

10

Osteoprotegerin, the bone protector, is a surprising target for beta-catenin signaling.

Boyce BF, Xing L, Chen D. Boyce BF, et al. Among authors: xing l. Cell Metab. 2005 Dec;2(6):344-5. doi: 10.1016/j.cmet.2005.11.011. Cell Metab. 2005. PMID: 16330319 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,873 results

Search Page

Filters